SCHEMBL6860748

SCHEMBL6860748

COc1cccc(-c2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccc(C(F)(F)F)cc4n3)c2O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
DGAT2 Q96PD7 7/20 0.35
GPR55 Q9Y2T6 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
CDK2 P24941 2/20 0.35
DYRK3 O43781 1/20 0.35
CCNT1 O60563 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6855342 0.91 DYRK1A (0.36) TDP1KDM4EHPGDSMN1; SMN2CDK2
SCHEMBL6863959 0.90 PTGDR2 (0.41) TDP1KDM4ERAB9ASMN1; SMN2CSNK1D
SCHEMBL6855844 0.84 PDE2A (0.39) CNR1CNR2SMN1; SMN2HCRTR1HCRTR2
SCHEMBL769323 0.79 SHBG (0.35) KDM4ENPC1RAB9ACSNK1D
SCHEMBL7937976 0.78 MAT2A (0.34) NPC1RAB9A
SCHEMBL6856099 0.78 NPC1 (0.43) CNR1CNR2KDM4ENPC1HPGD
SCHEMBL2638085 0.78 IDH1 (0.37) KDM4ENPC1RAB9ASMN1; SMN2PDE4A
SCHEMBL5643802 0.77 NPC1 (0.35) NPC1RAB9A
SCHEMBL29184810 0.76 SHBG (0.33) KDM4ENPC1RAB9A
SCHEMBL7520346 0.76 NPC1 (0.33) KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800676-B2 ULTRAVIOLET RADIATION ABSORBERS; HEAT AND OXIDATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-05 US claimed
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORP. 2003-01-02 US claimed
US-6800676-B2 ULTRAVIOLET RADIATION ABSORBERS; HEAT AND OXIDATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-05 US disclosed
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORP. 2003-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith SUV39H1, SUV39H2, TPST2 CNR1 4101/4885CNR2 3180/4885TDP1 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.